Clinical Trials
7 trialsNCT05683834 2026-04-22
Trial Evaluating the Immunogenicity and Safety of an Adjuvanted Epstein-Barr Virus (EBV) Glycoprotein 350 Vaccine in EBV-seronegative Persons
National Institutes of Health Clinical Center (CC)
Phase 1/2 Completed
NCT07428954 2026-02-24
LegitHealthSAN
AI Labs Group S.L
Completed
NCT01431326 2023-09-06
PTN_POPS
Duke University
Completed
NCT03702231 2023-08-04
Response to the SHINGRIX Varicella Zoster Virus (VZV) Vaccine in Chronic Lymphocytic Leukemia (CLL) and CLL Treated With Bruton's Tyrosine Kinase Inhibitor (BTK-I)
National Institutes of Health Clinical Center (CC)
Phase 2 Completed
NCT00478465 2022-05-27
Valganciclovir (Valcyte) for Chronic Fatigue Syndrome Patients Who Have Elevated Antibody Titers Against Human Herpes Virus 6 (HHV-6)and Epstein-Barr Virus (EBV)
Stanford University
Phase 1/2 Completed
NCT02715752 2016-04-26
A Retrospective Chart Review Study of Gene-Eden-VIR/Novirin
The Center for the Biology of Chronic Disease
Completed
NCT00739258 2012-01-23
Surveillance and Medical Help for HIV-infected Intravenous Drug Users in and Out of Prison
Kaohsiung Medical University Chung-Ho Memorial Hospital
Completed